Brief: Chuangmei Pharmaceutical says FY profit attributable rmb59.35 mln
March 22 (Reuters) - Chuangmei Pharmaceutical Co Ltd
2289.HK :
* Board recommends distribution of a final dividend of
rmb0.20 per share
* FY profit attributable to owners of company was rmb59.35
million, increasing by 125.15 percent
* In 2016, turnover of group was rmb3.67 billion, increasing
by 8.00% in 2015
Source text for Eikon: ID:nHKS1KSlwf
Further company coverage: 2289.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Charmacy Pharmaceutical Co
See all newsBrief: Charmacy Pharmaceutical Sees Decrease In Net Profit Attributable By 45% For Year
Brief: Charmacy Pharmaceutical Says Yao Chuanglong Ceased To Be Chairman
Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
Brief: Charmacy Pharmaceutical Says Controlling Shareholder To Provide Loan Facility
Brief: Charmacy Pharmaceutical Says Applied For Trading Resumption From Feb 17